Combo therapy trial achieves 94% remission rate for Hodgkin’s lymphoma
A combination of chemotherapy and immunotherapy has proven promising in treating patients with advanced Hodgkin Lymphoma, and removes the need for radiation therapy in kids. In a new phase 3 clinical trial, 94% of patients receiving the combo treatment… Continue reading Combo therapy trial achieves 94% remission rate for Hodgkin’s lymphoma